Page 1679 - Clinical Small Animal Internal Medicine
P. 1679
Index 1617
prognosis 1280, 1281 diagnosis/clinical staging central nervous system tumors
VetBooks.ir statistical interpretation for epidemiology 1231, 1236 cirrhosis 708
1232–1233, 1232, 1236–1238
signalment 1279
1248–1249, 1249
practitioners 7
etiology/pathophysiology
esophageal and stomach
treatment 1280 1231, 1236 cancers 1284
lung‐digit syndrome 1489–1490 extranodal forms of feline acromegaly 45
LUT see lower urinary tract lymphoma 1235–1237 forebrain disorders 775–776, 781,
luteinizing hormone (LH) 29 feline leukemia virus 878 783–787
LVOT see left ventricular feline lymphomas 1236–1239 fungal infections 996
outflow tract history and clinical signs gallbladder and extrahepatic biliary
Lyme borreliosis 941–944 1231–1232, 1232, 1236 ducts 724
diagnosis 942–943 intestinal cancers 1287–1292 gastrointestinal imaging 469, 472
epidemiology 941 prognosis 1235–1236, 1239 head trauma 750, 753–754, 754
etiology/pathophysiology 941 signalment 1231, 1236 hepatobiliary disease 659, 675
history and clinical signs treatment 1233–1235, 1234, meningoencephalitis and
941–942 1238–1239, 1238 meningomyelitis 798
Lyme arthritis 941–943 lymphopenia 859 motility disorders 569
Lyme nephritis 942, 943 Lynxacarus radovsky 1457–1458 myelopathy 819
One Health 4 diagnosis 1457–1458 neuroophthalmology 823, 825, 827
prevention 942, 943 etiology/pathophysiology 1457 oral tumors 1254
prognosis 943 history and clinical signs orbital and optic nerve
public health implications 944 1457, 1458 tumors 1268
signalment 941 treatment and prognosis 1458 osteoarthritis 1531
treatment 943 Lyssavirus spp. see rabies pancreatitis 594
lymphadenitis 951 pericardial disease 280
lymphadenomegaly 1348 m pituitary‐dependent
lymphangiectasia 522, 522 macrocirculation 405 hyperadrenocorticism 57
lymphatic dilation 513–514, 514 macrocyclic lactones 1452 pulmonary thromboembolism 319
lymphatic drainage 660 macrolides 1046 seizures and movement
lymph nodes macronodular hyperplasia 56 disorders 762
biology of cancer and cancer macrophage colony‐stimulating factors spinal cord injury 743–744, 744
genetics 1210 (M‐CSF) 1514–1515, 1515 vestibular disease 792–794
bone and joint tumors 1328–1329 macules maintenance fluids 362
hepatobiliary disease 664 approach to the dermatologic major histocompatibility complex
mast cell tumors 1360 patient 1383 (MHC) 1567–1569
melanoma 1348 atopic dermatitis 1404 Malassezia spp. 988–989
oral tumors 1254 miscellaneous skin diseases 1499 approach to the dermatologic
rectoanal diseases 609–610 magnesium homeostasis and patient 1376, 1391
soft tissue sarcomas 1334 disorders 1085–1088 bacterial pyodermas 1462, 1466
lymphocytic cholangitis (LC) biologic importance of diagnosis 988–989
687–690, 693 magnesium 1085–1086 epidemiology and signalment 988
lymphoid leukemias 1223–1225 distribution in the body 1085 etiology/pathophysiology 988
diagnosis 1224–1225, 1224–1225 etiology/pathophysiology history and clinical signs 988
epidemiology 1223–1224 1086–1087, 1087 miscellaneous skin diseases
etiology/pathophysiology 1223 hypermagnesemia 1087–1088 1495–1498, 1502, 1502
feline leukemia virus 878 hypomagnesemia 1086–1087 otitis externa 1474, 1474
history and clinical signs 1224 laboratory assessment 1086 public health implications 989
prognosis 1225 regulation of magnesium 1086 treatment and prognosis
signalment 1224 treatment 1087 989, 1052
treatment 1225 magnesium sulfate male feminizing syndrome 1488
lymphoma/lymphosarcoma supplementation 203–204 male reproductive system
1231–1239 magnetic resonance imaging (MRI) tumors 1311–1315
airway and lung cancers airway and lung cancers diagnosis 1311–1315, 1315
1277–1278 1278–1279 epidemiology 1311–1314
canine lymphomas 1231–1236 bone and joint tumors 1330 etiology/pathophysiology
cardiac neoplasia 1271–1274 cardiac neoplasia 1272–1273 1311–1314
